Circurna

Engineers proprietary circular RNA therapeutics and LNP formulations to deliver robust, sustained therapeutic protein expression. Provides improved tolerability, simplified cold‑chain logistics, and a patch-based, injection‑free delivery to broaden patient access across multiple disease areas.
Load...
Load...
Load...
Load...
Load...
Employees
loading...
Funding Status
loading...
Established
loading...
Total Funding
loading...
ARR
loading...

Insights

Loading Insights...
Q1/2040}
Loading Insight content to display...
Loading Insights...
Q1/2040}
Loading Insight content to display...
Founders
loading...
Notable Customers
loading...

Funding

Workforce

Functional Distribution
N/A
Open Positions
N/A
Diversity
N/A
Loading